BMJ analysis warns UK-US pharma deal risks 229,000 excess deaths in England by 2036
The UK-US pharmaceuticals deal will force the NHS to spend an extra £44.7 billion on branded medicines by 2036 without additional funding.
19 JUL
· 3 min read
